Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Boston Technology Review.
Press releases published on June 25, 2025
Biogen to Advance Investigational Spinal Muscular Atrophy Asset to Registrational Studies Based on Positive Interim Phase 1 Results
GlobeNewswire
·
June 25, 2025
Salanersen (BIIB115/ION306) is a novel antisense oligonucleotide (ASO) with the potential to achieve high efficacy and once yearly dosing in spinal muscular atrophy (SMA) Interim Phase 1 data show children with SMA previously treated with gene therapy …
Cognition Therapeutics Provides Regulatory Update on Zervimesine (CT1812) in Alzheimer’s Disease and Dementia with Lewy Bodies (DLB)
GlobeNewswire
·
June 25, 2025
- End-of-Phase 2 Meeting with FDA for Mild-to-Moderate Alzheimer’s Disease Scheduled - - Applications for IND and Breakthrough Status Filed for Dementia with Lewy Bodies - PURCHASE, N.Y., June 25, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the …
Verano Unveils Bodega-Style Dispensary Experience at Zen Leaf Cave Creek in Phoenix
GlobeNewswire
·
June 25, 2025
Flipping the script on the traditional dispensary format, the new bodega-style shopping experience offers customers the freedom to browse and select their favorite items directly from shelves featuring one of the largest assortments of directly accessible …
Plus Therapeutics Announces FDA Clearance of its Investigational New Drug Application using REYOBIQTM for the Treatment of Childhood Brain Cancer
GlobeNewswire
·
June 25, 2025
Phase 1/2a clinical trial currently supported by a $3.0 million grant from the U.S. Department of Defense Trial will enroll children with high grade glioma and ependymoma HOUSTON, June 25, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) ( …
Arbutus Reacquires Greater China Rights to Imdusiran and Announces Scientific Advisory Board with Late-Stage Clinical Focus
GlobeNewswire
·
June 25, 2025
Qilu Pharmaceutical and Arbutus mutually agree to conclude strategic partnership for imdusiran in Greater China Drs. Jordan Feld, Ed Gane, Anna Lok, Mark Sulkowski and Man-Fung Yuen join Arbutus Scientific Advisory Board WARMINSTER, Pa., June 25, 2025 ( …
Oncotelic Therapeutics Announces Publication of Landmark Study on TGFB2 Gene Methylation as a Positive Prognostic Marker in Pancreatic Cancer
GlobeNewswire
·
June 25, 2025
AGOURA HILLS, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) ("Oncotelic" or the "Company"), a clinical-stage biopharmaceutical company focused on RNA-based therapeutics, today announced the publication of a peer- …
MetasTx Secures NCI Grant to Enable the Advancement of Dual-Track Strategy Against Metastatic Prostate Cancer
GlobeNewswire
·
June 25, 2025
PITTSBURGH, June 25, 2025 (GLOBE NEWSWIRE) -- MetasTx, LLC, a biotechnology company focused on preventing the metastasis of solid tumor cancers – like prostate, breast and skin, announced today it has received a Small Business Innovation Research (SBIR) …
Kymera Therapeutics Announces Sanofi IRAK4 Collaboration Update
GlobeNewswire
·
June 25, 2025
Sanofi to advance Kymera’s next-generation oral IRAK4 degrader development candidate, KT-485, into clinical testing and will not advance KT-474 In preclinical testing, KT-485 demonstrated increased selectivity and potency with a favorable safety profile …
Portage Biotech Regains Full Compliance with Nasdaq Continued Listing Requirements
GlobeNewswire
·
June 25, 2025
DOVER, Del., June 25, 2025 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (“Portage” or the “Company”) (NASDAQ: PRTG), a clinical-stage immuno-oncology company formed under the laws of the British Virgin Islands (“Portage”), announced today that on June 24, 2025 …
Aquestive Therapeutics to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies of Anaphylm™ (epinephrine) Sublingual Film at the CFAAR Food Allergy Summit
GlobeNewswire
·
June 25, 2025
WARREN, N.J., June 25, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and …
Amicus Therapeutics Announces Approval of Pombiliti® (cipaglucosidase alfa) + Opfolda® (miglustat) in Japan
GlobeNewswire
·
June 25, 2025
PRINCETON, N.J., and TOKYO, June 25, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved Pombiliti (cipaglucosidase alfa) + Opfolda (miglustat) for the …
Wowza Acquires AVA Intellect as it Accelerates Commitment to AI-First Innovation Strategy
GlobeNewswire
·
June 25, 2025
Acquisition aligned with Wowza’s vision for intelligent video infrastructure, bringing agent-based automation to streaming orchestration and optimization. Wowza appoints AVA Intellect co-founder Mike Vitale as Head of Intelligence at Wowza. DENVER, June 25 …
Fraude sociale : Provence.ai met son IA à l’épreuve pour protéger notre modèle social
GlobeNewswire
·
June 25, 2025
Alors que la fraude sociale représente plusieurs milliards d’euros chaque année en France, Provence.ai, expert reconnu du traitement documentaire, déploie une solution innovante d'intelligence artificielle destinée à détecter efficacement les …
Coin Casino Launches Instant Crypto Withdrawal System with No ID Verification for U.S. Players
GlobeNewswire
·
June 25, 2025
SAN JUAN, Puerto Rico, June 25, 2025 (GLOBE NEWSWIRE) -- Coin Casino, a licensed crypto gaming platform, today announced the rollout of its Instant Crypto Withdrawal System, a major update that allows registered players to cash out winnings instantly and …
New Jitterbit Partner Program Enables Global Channel to Deliver Enterprise Automation, AI Agents
GlobeNewswire
·
June 25, 2025
ALAMEDA, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- Jitterbit, a global leader in accelerating business transformation for enterprise systems, today announced the global expansion of its partner program and new Jitterbit University partner curricula. …
First Patient Enrolled in Aclarion’s Groundbreaking CLARITY Trial
GlobeNewswire
·
June 25, 2025
The first CLARITY patient was enrolled at the Texas Back Institute, a world leader in advancing spine technology, science, and education, as well as patient care CLARITY is a randomized clinical trial designed to demonstrate Nociscan’s ability to improve …
Agillic approved as ‘SKI’ vendor for the Danish public sector
GlobeNewswire
·
June 25, 2025
Press release – Copenhagen, 25 June 2025 – Agillic A/S Agillic has been approved as a SKI vendor under the framework agreement ’02.06 standard software’, allowing organisations across state, regions, and municipalities to include Agillic’s marketing …
Haal meer uit de cloud met expertise van AWS en een MSP
GlobeNewswire
·
June 25, 2025
Amsterdam, Nederland, Juni 2025, Sean Tilley, Director of Sales EMEA bij 11:11 Systems, een provider van beheerde infrastructuuroplossingen, gaat dieper in op de basisinformatie van data voor de moderne onderneming en hoe die bedrijven in staat stelt te …
Transformez le cloud en levier de succès en alliant AWS à l’expertise des MSP
GlobeNewswire
·
June 25, 2025
Paris, France, juin 2025, Sean Tilley, directeur commercial senior chez 11:11 Systems, un MSP reconnu, examine le rôle essentiel des données dans l’entreprise moderne et leur importance pour son fonctionnement. Alors que la complexité et la richesse de l’ …
Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair® (omalizumab)
GlobeNewswire
·
June 25, 2025
REYKJAVIK, Iceland and PISCATAWAY, N.J. and LONDON, June 25, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacturing of biosimilar medicines for patients worldwide, Kashiv Biosciences LLC …